Works by Mulazzani, Matthias
Results: 8
Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1618, doi. 10.1093/neuonc/nox097
- By:
- Publication type:
- Article
APRIL and BAFF: novel biomarkers for central nervous system lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0796-4
- By:
- Publication type:
- Article
Cellular and Molecular Mechanisms of CD8+ T Cell Differentiation, Dysfunction and Exhaustion.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 19, p. 7357, doi. 10.3390/ijms21197357
- By:
- Publication type:
- Article
Clinical and psychological phenomenology of pain in autoinflammatory diseases.
- Published in:
- BMC Rheumatology, 2020, v. 4, n. 1, p. 1, doi. 10.1186/s41927-020-00168-x
- By:
- Publication type:
- Article
The Role of BAFF-R Signaling in the Growth of Primary Central Nervous System Lymphoma.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. 1, doi. 10.3389/fonc.2020.00682
- By:
- Publication type:
- Article
HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad024
- By:
- Publication type:
- Article
Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma.
- Published in:
- Clinical & Translational Immunology, 2021, v. 10, n. 5, p. 1, doi. 10.1002/cti2.1283
- By:
- Publication type:
- Article
Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice